alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 12.1**
**CEO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
I, Ennio De Rigo certify that:
1. I have reviewed this annual report on Form 20-F of De Rigo S.p.A.; 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisannual report; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this annualreport; 4. The Company’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-14 and 15d-14) for the company and have:
 a) Designed such disclosure controls and procedures or caused suchdisclosure controls and procedures to be designed under our supervisionto ensure that material information relating to the company, includingits consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this report isbeing prepared;  b) Evaluated the effectiveness of the company’s disclosure controlsand procedures and  c) presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures as of the end the period coveredby this report based on such evaluation;
5. The company’s other certifying officers and I have disclosed, based onour most recent evaluation, to the company’s auditors and the auditcommittee of the company’s board of directors (or persons performing theequivalent functions):
 a) all significant deficiencies and material weaknesses in the designor operation of internal controls of financial reporting which arereasonably likely to adversely affect the company’s ability to record,process, summarize and report financial information; and  b) any fraud, whether or not material, that involves management orother employees who have a significant role in the company’s internalcontrols over financial reporting; and  c) The company’s other certifying officers and I have indicated inthis report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internalcontrols subsequent to the date of our most recent evaluation,including any corrective actions with regard to significantdeficiencies and material weaknesses.
 /s/ Ennio De Rigo
<PAGE>   1





                                   EXHIBIT 23



                  CONSENT OF THE INDEPENDENT PUBLIC ACCOUNTANTS


HEARx Ltd.
West Palm Beach, Florida

        We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (filed September 13, 1994), Form S-8 (filed July 19,
1996), Form S-3 (File No. 333-4303), Form S-3 (File No. 333-4639), Form S-3
(File No. 333-11429) , Form S-3 (File No. 333-18753), Form S-3 (File No.
333-24357), Form S-3 (File No. 333-25169), Form S-3 (File No. 333-6457) and Form
S-3 (File No. 333-38862) of our report dated March 9, 2001, relating to the
consolidated financial statements and financial statement schedule of HEARx
Ltd., appearing in the Company's Annual Report on Form 10-K for year ended
December 29, 2000.




West Palm Beach, Florida                                        BDO Seidman, LLP
March 23, 2001



                                       56
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Crop Improvement and Protection Research: Salinas, CA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Salinas, California Crop Improvement and Protection Research People & Locations







Connie  Machuca
                        Crop Improvement and Protection Research

                        




                        
                        Biological Science Lab Technician
                        Phone: (831) 755-2879
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Wheat, Sorghum and Forage Research: Lincoln, NE
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Lincoln, Nebraska Wheat, Sorghum and Forage Research People & Locations







Emily K Fast
                        Wheat, Sorghum and Forage Research

                        




                        
                        Biological Science Aid
                        Phone: (402) 525-9797
                        
                        
                        Fax: (402) 472-4020(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

SHISHA SINGH-BALWINDER KOUR,

AKA Shisha Singh-Balwinder Kaur, AKA 

Sheesa Singh, AKA Sheesha Singh, AKA 

Shisha Singh

Petitioner,

 v.

JEFFERSON B. SESSIONS III, Attorney 

General,

Respondent.

No. 15-70625

Agency No. A200-064-866

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted June 14, 2018**

San Francisco, California

Before: SILER***, PAEZ, and IKUTA, Circuit Judges.

 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision without 

oral argument. See Fed. R. App. P. 34(a)(2).

*** The Honorable Eugene E. Siler, United States Circuit Judge for the U.S. 

Court of Appeals for the Sixth Circuit, sitting by designation. 

FILED

JUN 22 2018

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2

Shisha Singh-Balwinder Kour appeals the Board of Immigration Appeals’ 

(“BIA”) denial of his motion to reopen. For the following reasons, we deny the 

petition. 

As previously determined by this court, Kour “failed to provide sufficient 

evidence corroborating his testimony as to his identity” during his removal

proceedings. Kour v. Holder, 514 F. App’x 690, 690 (9th Cir. 2013). The BIA 

denied Kour’s subsequent motion to reopen based, in part, on his failure to 

demonstrate that his submitted passport could not have been obtained and

produced during his prior hearing. The BIA grants motions to reopen only if 

“evidence sought to be offered . . . was not available and could not have been 

discovered or presented at the former hearing.” 8 C.F.R. § 1003.2(c)(1). 

Because the BIA has significant discretion in determining whether to reopen 

a matter, we employ the deferential abuse-of-discretion standard of review on 

appeal, INS v. Doherty, 502 U.S. 314, 323 (1992), affirming the BIA’s decision 

unless it is “arbitrary, irrational, or contrary to law,” Singh v. INS, 295 F.3d 1037, 

1039 (9th Cir. 2002). Kour did not explain to the BIA why he could not have 

presented his old passport during the previous proceedings, given that Kour’s new 

passport indicated that his prior passport had been returned and cancelled. 

Furthermore, Kour’s statements during his earlier removal hearing made clear that 

he had not attempted to obtain a new passport. Consequently, the BIA’s 
3

determination that Kour failed to meet the requirements of a motion to reopen was 

not arbitrary, irrational, or contrary to law. Additional evidence of Kour’s identity 

was previously available, and he did not provide the BIA with a reasonable 

explanation as to why this evidence was not provided as part of his original 

removal proceedings. See 8 C.F.R. § 1003.2(c)(1).

PETITION FOR REVIEW DENIED.
&NM 'airVIBEEPT fir

, facts de novo. Lader v. Warden, 121 Nev. 682, 686, 120 P.3d 1164, 1166 (2005). Barajas failed to demonstrate that he was entitled to any additional credit. See NRS 176.055(1) (providing that a defendant will be given credit for the amount of time spent in confinement prior to conviction unless the confinement was pursuant to the judgment of conviction for a different offense); see also McMichael v. State, 94 Nev. 184, 194, 577 P.2d 398, 404 (1978) ("Only incarceration pursuant to a charge for which sentence is ultimately imposed can be credited against that sentence."), overruled on other grounds by Meador v. State, 101 Nev. 765, 711 P.2d 852 (1985), and abrogated on other grounds by Braunstein v. State, 118 Nev. 68, 40 P.3d 413 (2002). And Barajas' reliance on Johnson v. State, 120 Nev. 296, 89 P.3d 669 (2004), is misplaced because Johnson only mandates presentence incarceration credit for sentences ordered to run concurrently within a single judgment of conviction. Johnson does not mandate presentence incarceration credit where the sentences are ordered to run concurrently in separate judgments of conviction. Accordingly, we

ORDER the judgment of the district court AFFIRMED.

SUPREME COURT

OF NEVADA

(0) I947A 2:WMitION1151111112 I rIEREFTX • : 21k1

cc: Second Judicial District Court Dept. 8 Law Office of Thomas L. Qualls, Ltd. Attorney General/Carson City Washoe County District Attorney Washoe District Court Clerk

SUPREME COURT

OF NEVADA

(0) 1947A • 3
ex10-2.htm


    
      

      

    

    EXHIBIT
10.2

     

    FAIRWAY
DAIRY & INGREDIENTS, L.L.C.

    17725
Juniper Path

    Lakeville, Minnesota 55044

    October
30, 2008

     

    Galaxy
Nutritional Foods, Inc.

    5955 T.G.
Lee Boulevard, Suite 201

    Orlando, Florida 32822

    


    Re:  Employment
Continuation – Michael E. Broll  via email
and Priority

    mebroll@galaxyfoods.com

    Dear Mr.
Broll:

    


    This
letter sets forth my understanding respecting the continuation of your
employment with Galaxy Nutritional Foods, Inc. and/or its successor
organizations (“Galaxy”) after completion of our purchase of a controlling
interest in Galaxy. My understanding of these terms is as follows,
namely:

    


    
      	
               
      

            	
              1.

            	
              I
      would request that you continue as Chief Executive Officer and Board
      Member of Galaxy through March 31,
2009.

            


    

    


    
      	
               
      

            	
              2.

            	
              It
      would be my hope that we mutually re-negotiate an Employment Agreement
      between Galaxy and you prior to March 31, 2009. In the event that we
      cannot re-negotiate an Employment Agreement or, in the event that either
      you or Galaxy decides that it is not in their best interest to continue
      your employment with Galaxy, then, and in that event, Galaxy would accept
      and you would tender your resignation as of March 31,
  2009.

            


    

    


    
      	
               
      

            	
              3.

            	
              Upon
      receipt of your resignation from Galaxy and its Board of Directors on
      March 31, 2009, then, and in that event, in consideration of your staying
      with Galaxy during the transition period subsequent to the change of
      control in Galaxy and in recognition of your waiver of your present Galaxy
      Stay Bonus, Galaxy will pay to you compensation of $20,000.00 per month
      for 25 consecutive months beginning on April 1, 2009 less any applicable
      federal and/or state taxes.

            


    

    


    
      	
               
      

            	
              4.

            	
              There
      may be other issues to be considered such as COBRA, pension benefits or
      other matters which need be considered and which we will deal with on or
      before March 31, 2009.

            


    

    


    In any
event, if you find the above terms to be acceptable, please execute one copy of
this letter and return it to me at your convenience. I look forward to working
with you.


    
      
         


      

      
        1

        
          

        

      

      
         


      

    


    


    Best
regards,

     

    /s/ Tim
Krieger

    


    Tim
Krieger

    I accept
the above employment continuation.

    


    


    Dated:      November
18, 2008                   /s/ Michael E.
Broll        

    Michael
E. Broll

    



    
      
         


      

      
        2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Extension of comment period.

# SUMMARY:

On June 24, 2021, NIOSH opened a notice to request information on the Needs and Challenges in Personal Protective Equipment (PPE) Use for Underserved User Populations. Written comments were to be received by August 23, 2021. NIOSH is extending the public comment period to October 15, 2021.

# DATES:

The comment period for the document published on June 24, 2021 (86 FR 33296), is extended. Comments must be received by October 15, 2021.

# ADDRESSES:

                        Interested parties should submit information to: NIOSH, Attn: Sherri Diana, National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998, Email address:                         *ppeconcerns@cdc.gov.*

# FOR FURTHER INFORMATION CONTACT:

                        N. Katherine Yoon, Ph.D., National Institute for Occupational Safety and Health Centers for Disease Control and Prevention Email Address:                         *NYoon@cdc.gov,*                         Phone number: 412-386-6752 [non-toll-free number].                    

# SUPPLEMENTARY INFORMATION:

                    NIOSH published a notice and request for information in the                     **Federal Register**                     on June 24, 2021 (86 FR 33296) regarding the                     *Needs and Challenges in Personal Protective Equipment (PPE) Use for Underserved User Populations.*                     This notice announces the extension of the comment period until October 15, 2021.                

Frank J. Hearl,

Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.

[FR Doc. 2021-17485 Filed 8-13-21; 8:45 am]

BILLING CODE 4163-18-P
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO
18 U.S.C SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the quarterly report of Docucorp International, Inc. (the Company) on Form
10-Q for the period ended April 30, 2005 as filed with the Securities and Exchange Commission on
the date hereof (the Report), I, John H. Gray, Senior Vice President, Finance and Administration
of the Company, certify, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:  (1)
    The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the
Securities and Exchange Act of 1934; and(2)
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. /s/ John H. GrayJohn H. GraySenior
Vice President, Financeand Administration(Principal Financial Officer)June 7, 2005
<PAGE>   1
                                                                     Exhibit 21


                             TUSCARORA INCORPORATED

                              List of Subsidiaries
                              --------------------

      The following is a complete list of the subsidiaries of the Company:

                                                    Jurisdiction of 
        Name of Subsidiary                           Incorporation
------------------------------------------       ----------------------
Alpine Packaging, Inc. (1)                              Colorado

Tuscarora International, Inc. (1)                       Delaware
  Tuscarora, S.A. de C.V. (2)                           Mexico
  Tuscarora de Mexico, S.A. de C.V. (2)                Mexico

Tuscarora Limited (1)                                   England
  Tuscarora (Scotland) Limited (3)                     England


------------

(1)  100% owned by Tuscarora Incorporated.
(2)  100% owned by Tuscarora International, Inc.
(3)  100% owned by Tuscarora Limited.
exv10w3






Exhibit 10.3




Alseres Pharmaceuticals, Inc.

239 South Street

Hopkinton, MA 01748




Robert L. Gipson

Ingalls & Snyder, LLC

61 Broadway

New York, NY 10006




Ladies and Gentlemen:




     Reference is hereby made to that certain Securities Purchase Agreement, of even date herewith,
by and between Alseres Pharmaceuticals, Inc. (the “Company”) and the Investors listed therein (the
“Purchase Agreement”). Capitalized terms not otherwise defined shall have the meaning ascribed to
them in the Purchase Agreement.



     As an inducement to enter into the Purchase Agreement, the Company has agreed to extend to you
certain rights. If the Company sells any shares of its Common Stock to an individual or entity
after the Initial Closing and before December 31, 2009 you shall be entitled to receive (as an
Investor in the Initial Closing) additional shares of Common Stock and Warrants in accordance with
the formula set forth in paragraph C of the Preamble to the Purchase Agreement.



     These rights shall not apply to: (a) the issuance of any shares of Common Stock as a stock
dividend to holders of Common Stock or upon any subdivision or combination of shares of Common
Stock, (b) the issuance of shares of Common Stock or options with respect thereto (subject in
either case to appropriate adjustment for stock splits, stock dividends, recapitalizations and
similar events occurring after the date of this Agreement), issued or issuable to employees,
directors or officers of, or consultants to, the Company or any Subsidiary pursuant to any plan,
agreement or arrangement approved by the Board of Directors of the Company or (c) the issuance of
securities solely in consideration for the acquisition (whether by merger or otherwise) by the
Company or any Subsidiary of all or substantially all of the stock or assets of any other entity.



     These rights shall terminate upon the earlier of (i) December 31, 2009 or (ii) the sale of all
or substantially all of the assets of the Company, whether by merger, share exchange or otherwise.



     The Company shall not be allowed to sell or issue any shares of Common Stock or Warrants if
such sale or issuance when combined with any shares previously sold under the Purchase Agreement
and any shares issuable under this agreement in total would result in the issuance of an excess of
4,000,000 shares of Common Stock or 19.99% of the then outstanding Common Stock of the Company,
when taken together with all of the shares of Common Stock (including Warrant Shares) issued
pursuant to the Purchase Agreement.



 









 





     Any shares of Common Stock and Warrants issued pursuant to this Agreement shall be subject to
the terms and conditions of the Purchase Agreement.



     EXECUTED as of the date set forth above to be governed by the laws of the State of Delaware.



	 	 	 	 	 
	 	ALSERES PHARMACEUTICALS, INC

 	 
	 	By:  	/s/ Kenneth L. Rice
 	 
	 	Name:  Kenneth L. Rice 	 
	 	Title:   EVP & CFO 	 
	 



Agreed to and acknowledged as of the date set forth above:




Investor:




	 	 	 	 	 
	By:

	 	/s/ Robert L. Gipson
 

	 	 
	Robert L. Gipson